Back to search

France· FR:66743830

REFACTO AF 3000 UI, poudre et solvant pour solution injectable en seringue préremplie

A moroctocog alfa product containing moroctocog alfa, registered in France by PFIZER EUROPE MA EEIG (BELGIQUE). The same ATC class is registered in 2 of our 19 countries.

ATC B02BD31

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedREFACTO AF 3000 UI, poudre et solvant…ATCB02BD31REGISTER NO.FR:66743830PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Moroctocog alfa is registered in 2 of 19 countries.

Countries holding a registration under ATC B02BD31 (moroctocog alfa), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 1 of them publish a price we can compare per daily dose

Moroctocog alfa · ATC B02BD31

2 / 19 countries

  • Franceprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
MOROCTOCOG ALFA
Manufacturer
PFIZER EUROPE MA EEIG (BELGIQUE)
Country
France (FR)
ATC code
B02BD31
ATC class
Moroctocog alfa
Defined daily dose
1 TSD, E
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400957988012
    1 seringue(s) préremplie(s) en verre de 3000 UI - 1 seringue(s) préremplie(s) en verre de 4 ml avec matériel(s) de perfusion avec tampon(s) alcoolisé(s) avec pansement(s)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e433b0ce-4e30-4712-91f7-58ead5341974
GET /v1/drugs/e433b0ce-4e30-4712-91f7-58ead5341974?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "66743830",
  "date_amm": "2011-05-06",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/99/103",
  "substance": "MOROCTOCOG ALFA",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "poudre et  solvant pour solution injectable",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about moroctocog alfa.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.